Reaction
Aortic Valve Disease reporting signals
As of the last recalculation, Aortic Valve Disease appears in 1,597 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 15.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Captopril | 11 | 15.0 | 15.0 |
| Gentamicin | 13 | 13.1 | 13.1 |
| Metolazone | 11 | 12.8 | 12.8 |
| Gentamicin Sulfate | 15 | 12.5 | 12.5 |
| Tafamidis | 10 | 11.1 | 11.1 |
| Zidovudine | 11 | 10.8 | 10.8 |
| Warfarin Sodium | 36 | 10.3 | 10.3 |
| Apixaban | 51 | 10.2 | 10.2 |
| Bleomycin Sulfate | 8 | 10.1 | 10.1 |
| Human Insulin | 8 | 8.4 | 8.4 |
| Raltegravir | 10 | 7.9 | 7.9 |
| Sotalol Hydrochloride | 10 | 7.9 | 7.9 |
| Agalsidase Beta | 5 | 7.1 | 7.1 |
| Linezolid | 13 | 5.7 | 5.7 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 17 | 4.9 | 4.9 |
| Sevelamer Carbonate | 3 | 3.4 | 3.4 |
| Ixazomib | 6 | 2.7 | 2.7 |
| Somatropin | 15 | 2.7 | 2.7 |
| Alirocumab | 5 | 2.6 | 2.6 |